Keyword: Sanofi

News

Novartis and Lilly Clinch Animal Health Deal

23.04.2014 - In one of several deals announced just after Easter, Swiss drugmaker Novartis said it would sell its animal health arm to U.S. rival Eli Lilly for about $5.4 billion. Lilly said...

News

U.S. Sanofi Executive Sentenced for Insider Trading

22.04.2014 - A former executive of French drugmaker Sanofi, Mark Cupo, has been sentenced to 16 months in prison in the U.S. for insider trading, after cooperating with prosecutors. A judge in...

News

Sanofi Eyes More Acquisitions, Sees Growth in Africa

03.04.2014 - Sanofi is on the lookout for acquisitions to boost key business units such as consumer and animal health products and expects strong growth on the "strategic continent" of Africa...

News

Sanofi and Munich University to Cooperate on Drug Development

24.03.2014 - French drugmaker Sanofi has agreed to form a three-year strategic partnership on drug development with Ludwig-Maximilians-University and the university clinic of Munich, Germany...

News

Novo Nordisk Sees Chance of U.S. Tresiba Launch Before Rivals

21.03.2014 - Novo Nordisk should still be able to introduce its long-acting insulin Tresiba on the U.S. market before rival products, despite being hit by a delay, the CEO of the Danish...

News

Bayer, Novartis said to Eye Merck & Co consumer health unit

21.02.2014 - A handful of consumer and healthcare companies including Germany's Bayer and Switzerland's Novartis are exploring a deal for Merck & Co's consumer healthcare business, people...

News

Sanofi Challenges Lilly’s Challenge of Lantus Patents

01.02.2014 - Paris-based pharmaceuticals producer Sanofi has filed a patent infringement suit against U.S. drugmaker Eli Lilly, claiming that its U.S. rival infringed four of its patents for...

News

Sanofi Share Buyback from L’Oreal could be “accretive,” CEO says

27.01.2014 - Buying back L'Oreal's 9% stake in Sanofi could be "very accretive" for the French drugmaker, although the idea remains speculative, Sanofi's CEO Chris Viehbacher told the news...